Multaq (Cardinal Health)


Welcome to the PulseAid listing for the Multaq drug offered from Cardinal Health. This Antiarrhythmic [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cardinal Health
NON-PROPRIETARY NAME: Dronedarone
SUBSTANCE NAME: DRONEDARONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiarrhythmic [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-07-01
END MARKETING DATE: 0000-00-00


Multaq HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMultaq from Cardinal Health
LABELER NAME: Cardinal Health
DEA SCHEDULE:
ACTIVE STRENGTH: 400(mg/1)
START MARKETING DATE: 2009-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55154-8104_6800dc1a-a82f-43a2-9ea0-571fe4675271
PRODUCT NDC: 55154-8104
APPLICATION NUMBER: NDA022425

Other DRONEDARONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthMultaq
Physicians Total Care, Inc.Multaq
Sanofi Winthrop IndustriesMultaq
sanofi-aventis U.S. LLCMultaq